HANK & LIN'S GROUP

The past is prologue and the future is scintillating

Theranostics: 

68Ga/177Lu-DOTA-HBED-FAPI

68Ga/177Lu-Nitroimidazole-FAPI

  1. Luo, Yang, et al. "Development of [68Ga] Ga/[177Lu] Lu-FAPI using dual-chelator DOTA-HBED." Journal of Nuclear Medicine 65 (supplement 2), (2024): 241522

  2. Luo, Yang, et al. "Development of [68Ga] Ga/[177Lu] Lu-DOTA-NI-FAPI-04 containing nitroimidazole moiety as new FAPI radiotracers with improved tumor uptake and retention." Journal of Nuclear Medicine 65 (supplement 2), (2024):241526

  3. Haiyan Hong, Zhihao Zha, Ruiyue Zhao, Yang Luo, Wenbin Jin, Linlin Li, Ran Wang, Li Yan, Hui Wang, Karl Ploessl, Jinping Qiao, Lin Zhu,and Hank F. Kung. [68Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor Uptake. Molecular Pharmaceutics.(2023) 20 (4):2159-2169. https://doi.org/10.1021/acs.molpharmaceut.2c01112

  4. Luo, Yang, et al. "Development of [68Ga] Ga/[177Lu] Lu-DOTA-NI-FAPI-04 Containing a Nitroimidazole Moiety as New FAPI Radiotracers with Improved Tumor Uptake and Retention."Journal of Medicinal Chemistry(2025), 68,348-360. https://doi.org/10.1021/acs.jmedchem.4c02015